Metabolism of digoxin and digoxigenin digitoxosides in rat liver microsomes: involvement of cytochrome P4503A

References

• ANTMAN, E. M. and SMITH, T. W., 1985, Digitalis toxicity. Annual Review of Medicine, 36, 357-367. CHANG, T. K., GONZALEZ, F. J. and WAXMAN, D. J., 1994, Evaluation of triacetyloleandomycin, a- naphthoflavone and diethyldithiocarbamate as selective chemical probes for inhibition of human cytochromes P450. Archives of Biochemistry and Biophysics, 311, 437–442.
   Google Scholar
• CORREIA, M. A., 1995, Rat and human liver cytochromes P450. In P. R. Ortiz de Montellano (ed.), Cytochrome P450: Structure, Mechanism, and Biochemistry (New York: Plenum), pp. 607–630.
   Google Scholar
• GAULT, H., KALRA, J., AHMED, M., KEPKAY, D. and BARROWMAN, J., 1980, Influence of gastric pH on digoxin biotransformation. I. Intragastric hydrolysis. Clinical Pharmacology and Therapeutics, 27, 16–21.
   PubMed Web of Science ®Google Scholar
• GAULT, H., KALRA, J., AHMED, M., KEPKAY, D., LONGERICH, L. and BARROWMAN, J., 1981, Influence of gastric pH on digoxin biotransformation. II. Extractable urinary metabolites. Clinical Phar-macology and Therapeutics, 29, 181–190.
   PubMed Web of Science ®Google Scholar
• GUENGERICH, F. P., 1988, Oxidation of 17a-ethynylestradiol by human liver cytochrome P-450. Molecular Pharmacology, 33,500–508.
   PubMed Web of Science ®Google Scholar
• GUENGERICH, F. P., 1989, Analysis and characterization of enzymes. In A. W. Hayes (ed.), Principles and Methods of Toxicology (New York: Raven), pp. 777–814.
   Google Scholar
• GUENGERICH, F. P., 1990, Mechanism-based inactivation of human liver microsomal cytochrome P-450 II1A4 by gestodene. Chemical Research in Toxicology, 3, 363–371.
   PubMed Web of Science ®Google Scholar
• HARRISON, L. I. and GIBALDI, M., 1976, Pharmacokinetics of digoxin in the rat. Drug Metabolism and Disposition, 4, 88–93.
   PubMed Web of Science ®Google Scholar
• HEDMAN, A. and MEIJER, D. K., 1998, Stereoselective inhibition by the diastereomers quinidine and quinine of uptake of cardiac glycosides into isolated rat hepatocytes. Journal of Pharmaceutical Sciences, 87, 457–461.
   PubMed Web of Science ®Google Scholar
• HELLER, M., 1990, Cardiac glycosides. New/old ideas about old drugs. Biochemical Pharmacology, 40, 919–925.
   PubMed Web of Science ®Google Scholar
• KELLY, R. A. and SMITH, T. W., 1996, Pharmacological treatment of heart failure. In J. G. Hardman and L. E. Limbird (eds), Goodman & Gilman' s The Pharmacological Basis of Therapeutics, 9th edn (New York: McGraw-Hill), pp. 809–838.
   Google Scholar
• KLAASSEN, C. D., 1974, Effect of microsomal enzyme inducers on the biliary excretion of cardiac glycosides. Journal of Pharmacology and Experimental Therapeutics, 191, 201–211.
   PubMed Web of Science ®Google Scholar
• LACARELLE, B., RAHMANI, R., DE SOUSA, G., DURAND, A., PLACIDI, M. and CANO, J. P., 1991, Metabolism of digoxin, digoxigenin digitoxosides and digoxigenin in human hepatocytes and liver microsomes. Fundamental and Clinical Pharmacology, 5, 567–582.
   PubMed Web of Science ®Google Scholar
• MAHNKE, A., STROTKAMP, D., Roos, P. H., HANSTEIN, W. G., CHABOT, G. G. and NEE, P., 1997, Expression and inducibility of cytochrome P450 3A9 (CYP3A9) and other members of the CYP3A subfamily in rat liver. Archives of Biochemistry and Biophysics, 337, 62–68.
   PubMed Web of Science ®Google Scholar
• NEWTON, D. J., WANG, R. W. and Lu, A. Y., 1995, Cytochrome P450 inhibitors. Evaluation of specificities in the in vitro metabolism of therapeutic agents by human liver microsomes. Drug Metabolism and Disposition, 23, 154–158.
   PubMed Web of Science ®Google Scholar
• OLINGA, P., MEREMA, M., HOF, I. H., SLOOF, M. J., PROOST, J. H., MEIJER, D. K. and GROOTHUIS, G. M., 1998, Characterization of the uptake of rocuronium and digoxin in human hepatocytes: carrier specificity and comparison with in vivo data. Journal of Pharmacology and Experimental Therapeutics, 285, 506–510.
   PubMed Web of Science ®Google Scholar
• RODIN, S. M. and JOHNSON, B. F., 1988, Pharmacokinetic interactions with digoxin. Clinical Pharma-cokinetics, 15, 227–244.
   PubMed Web of Science ®Google Scholar
• Roos, P. H. and MAHNKE, A., 1996, Metabolite complex formation of orphenadrine with cytochrome P450. Involvement of CYP2C11 and CYP3A isozymes. Biochemical Pharmacology, 52, 73–84. SCHMOLDT, A. and AHSENDORF, B., 1980, Cleavage of digoxigenin digitoxosides by rat liver microsomes.
   Google Scholar
• European Journal of Drug Metabolism and Pharmacokinetics, 5, 225–232.
   Google Scholar
• SESARDIC, D., Booms, A. R., MURRAY, B. P., MURRAY, S., SEGURA, J., DE LA TORRE, R. and DAVIES, D. S., 1990, Furafylline is a potent and selective inhibitor of cytochrome P450IA2 in man. British Journal of Clinical Pharmacology, 29, 651–663.
   PubMed Web of Science ®Google Scholar
• WACHER, V. J., Wu, C. Y. and BENET, L. Z., 1995, Overlapping substrate specificities and tissue distribution of cytochrome P450 3A and P-glycoprotein: implications for drug delivery and activity in cancer chemotherapy. Molecular Carcinogenesis, 13, 129–134.
   PubMed Web of Science ®Google Scholar
• WANG, H. and STROBEL, H. W., 1997, Regulation of CYP3A9 gene expression by estrogen and catalytic studies using cytochrome P450 3A9 expressed in Escherichia coli. Archives of Biochemistry and Biophysics, 344, 365–372.
   PubMed Web of Science ®Google Scholar
• WEINHOUSE, E., KAPLANSKI, J. and GENCHIK, G., 1985, Plasma and tissue levels of digoxin in the rat following pretreatment with verapamil. Research Communications in Chemical Pathology and Pharmacology, 47, 469–472.
   PubMedGoogle Scholar
• WEINHOUSE, E., KAPLANSKI, J., ZALZSTEIN, E., GENCHIK, G., COLTON, D. and NUDEL, D., 1988, Mechanisms of digoxin-amiodarone interaction in the rat. Proceedings of the Society of Experimental Biology and Medicine, 188, 96–102.
   PubMed Web of Science ®Google Scholar
• WIRTH, K. E. and FROLICH, J. C., 1974, Effect of spironolactone on excretion of 'H-digoxin and its metabolites in rats. European Journal of Pharmacology, 29, 43–51.
   PubMed Web of Science ®Google Scholar